Navigation Links
Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to January 4, 2008
Date:12/28/2007

00. Of this amount, $54,947,000 was placed in trust. Echo common stock trades on the OTC Bulletin Board under the symbol EHHA.OB. To learn more about Echo, visit the website at http://www.echohealthcare.com.

About XLNT Veterinary Care, Inc.

XLNT Veterinary Care, Inc. is a provider of veterinary primary care and specialized services to companion animals through a network of fully-owned veterinary hospitals. XLNT currently owns and operates 26 veterinary hospitals in the State of California.

Additional Information about the Merger and Where to Find It

Echo has filed a Registration Statement on Form S-4 with the SEC in connection with the merger, and has mailed a Proxy Statement/Prospectus concerning the proposed merger transaction to stockholders of record as of November 7, 2007. INVESTORS AND SECURITY HOLDERS OF ECHO ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION ABOUT ECHO, XLNT, THE MERGER AND RELATED MATTERS. Investors and security holders may obtain the documents free of charge at the SEC's web site at http://www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by Echo by directing a written request to: Corporate Secretary, Echo Healthcare Acquisition Corp., 8000 Towers Crescent Drive, Suite 1300, Vienna, VA 22182, or by visiting Echo's web site at http://www.echohealthcare.com. Investors and security holders are urged to read the proxy statement/ prospectus and the other relevant materials when they become available before making any voting or investment decision with respect to the merger.

In addition to the Registration Statement, proxy statement/prospectus and supplements to the proxy statement/prospectus, Echo files annual, quarterly and special rep
'/>"/>

SOURCE Echo Healthcare Acquisition Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
3. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
4. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. MDS to Present at Thomas Weisel Partners Healthcare Conference
7. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
8. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
11. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive...and iPod Touch. , Mountai...n,s most popular and addictive game, SplitWords, i...t Words is designed to help banish that ,tip of th...Phone brain game challenges the brain by encourag...
(Date:11/21/2009)... Linwood Group ask whether there is a sec...red? , London, UK (PRWEB)...th up to one in three of the adult UK population d...ing alcohol-related liver disease*, it is hardly a...habilitation programmes and residential centres fo...
(Date:11/20/2009)...HINGTON, Nov. 20 The A... to modify health care reform legislation released...a health insurance individual coverage mandate. Th... mandate will minimize adverse selection stemming ...ribed by the bill. ,, "The individual mandate l...
(Date:11/20/2009)... Senators and Congressmen in Competitive ... Health Care Vote , Washi...d congressmen running for re-election next year in...Charlie Cook, may come to regret voting for House ...ording to a breaking Zogby International/ O’...
(Date:11/20/2009).... LOUIS, Nov. 20 Cente... it will present at the Bank of America Merrill Ly...3, 2009, at the Crowne Plaza Hotel Times Square in...ay, December 2nd at 8:30 a.m. Eastern Time. Invest..., audio webcast of Centene,s presentation at: htt...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
... Applicants for Social Security Di...y; Allsup Answers Common Benefits Questions , ..., 2008 -- People who find themselves with a mental... about a person’s life changes, the past sti...
... Central Bucks Specialists, a lead...s MxSecure, Inc., the nation's leading provid... clinics, as their outsourced medical transcriptio...n's leading provider of medical transcription...
...ne of few trials to recruit large percentage of Af...ipants, PORTLAND, Ore., July 8 Keeping a food di... a study from Kaiser Permanente,s Center,for Healt...ssue of the American Journal of Preventive Medicin...
...ILLS, Calif., July 7 "For several months,senior l...orking on a,settlement agreement with the Californ...ure to all issues relating to previous rescissions...,review our proposal., Following are the key elem...
...uly 7 Ventas, Inc. (NYSE: VTR ),("Ventas" or the... 2008,second quarter earnings release after the cl...ence call to discuss those earnings will be held o...any,s website at http://www.ventasreit.com or at...
... Ill., July 7 The University HealthSystem,Consort... newly created,position of Chief Learning Officer....e in academic internal medicine and comes to UHC f...ingleton was the Petersdorf Scholar in Residence a...
Other Medicine News:Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 2Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4Health News:Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care 2Health News:University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer 2
(Date:11/19/2009)...an, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a lea...edients (APIs), announced that its,Tainan facility...tion from,SafeBridge(R) Consultants, Inc. The Cert...ficiency in the safe handling of potent active,pha...cific laboratories and,production areas used for t...
(Date:11/19/2009)..., Nov. 19 The D e al ...f its Most Admired Corporate Dealmakers for the se...as its Most Admired Dealmaker in pharma/biotech fo... and divestitures since January 2006. ,, Over t...ortfolio with a focus on high-growth, innovation-d...
(Date:11/19/2009)...ational Internet Week of Action ,, SILVER SPRI...S. Food and Drug Administration today completed a ...d the International Internet Week of Action (IIWA)...al products. ,, (Logo: http://www.newscom.com/...ffort, the FDA,s Office of Criminal Investigations...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2CareFusion Launches New Brand Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety 50517 1CareFusion Launches New Brand Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety 50517 2CareFusion Launches New Brand Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety 50517 3BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 1BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 2Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 1Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 2Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 3
...um: The Takeda Oncology,Company today reported upd...ed Phase III clinical trials of VELCADE based comb...-eligible patients with previously untreated,multi...val (PFS) was observed,in one study comparing VELC...mycin and dexamethasone (VAD), as well as in anoth...
...sts that ofatumumab has activity in heavily pre-tr... , , , PHILADELPHIA, Dec. 8 GlaxoSmithKli... positive results from a pivotal trial pre-planned...he treatment of refractory chronic lymphocytic leu... of ofatumumab for heavily pre-treated patients wi...
Other Medicine Technology:Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 2Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 3Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 4Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 5Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 6Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 7Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 8Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) 9
...pose agarose, has been developed for analytical an... separation of high molecular weight DNA [pulsed-f...high gel strength agarose ( 1800 g/cm2, 1%). T...trations of agarose in electrophoretic gels. The a...
Agarose, high gel strength, Molecular Biology Grade
UltraClean™ Forensic Agarose
...se 1000 is specifically formulated for high resolu...This standard melting temperature agarose can reso...ce in size. UltraPure™ Agarose 1000 gels ex...nd improved clarity for enhanced visibility of fra...
Medicine Products: